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Screening of 31 genes involved in
monogenic forms of obesity in 23 Pakistani
probands with early-onset childhood
obesity: a case report
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Abstract
Background: Consanguine families display a high degree of homozygosity which increases the risk of family
members suffering from autosomal recessive disorders. Thus, homozygous mutations in monogenic obesity genes
may be a more frequent cause of childhood obesity in a consanguineous population.
Methods: We identified 23 probands from 23 Pakistani families displaying autosomal recessive obesity. We have
previously excluded mutations in MC4R, LEP and LEPR in all probands. Using a chip-based, target-region capture
array, 31 genes involved in monogenic forms of obesity, were screened in all probands.
Results: We identified 31 rare non-synonymous possibly pathogenic variants (28 missense and three nonsense)
within the 31 selected genes. All variants were heterozygous, thus no homozygous pathogenic variants were found.
Two of the rare heterozygous nonsense variants identified (p.R75X and p.R481X) were found in BBS9 within one
proband, suggesting that obesity is caused by compound heterozygosity. Sequencing of the parents supported the
compound heterozygous nature of obesity as each parent was carrying one of the variants. Subsequent clinical
investigation strongly indicated that the proband had Bardet-Biedl syndrome.
Conclusions: Mutation screening in 31 genes among probands with severe early-onset obesity from Pakistani
families did not reveal the presence of homozygous obesity causing variants. However, a compound heterozygote
carrier of BBS9 mutations was identified, indicating that compound heterozygosity must not be overlooked when
investigating the genetic etiology of severe childhood obesity in populations with a high degree of consanguinity.
Keywords: Autosomal recessive, Bardet-Biedl syndrome 9, Compound heterozygous, Early-onset obesity,
Monogenic obesity, Pakistani families, Consanguinity
Background
Worldwide, the prevalence of obesity has risen more
than tenfold during the past four decades and approxi-
mately124 million children and adults, aged five to 19
years old, were obese in 2016 [1]. Obesity is one of the
major risk factors for metabolic syndrome, including
arterial hypertension, cardiovascular disease, diabetes
mellitus, dyslipidemia and cancer [2, 3]. The etiology of
obesity comprises both environmental and genetic fac-
tors, with a heritability of body mass index (BMI) be-
tween 40 to 70% [4, 5].
In rare monogenic forms of obesity, disruption of a
single gene is the cause obesity and individuals typically
display severe early-onset obesity along with hyperphagia
and endocrine disorders [6, 7]. Most of the causative
proteins in monogenic forms of obesity are acting in the
hypothalamic leptin-melanocortin signalling pathway,
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which is essential for the regulation of food intake, body
weight and energy regulation [8, 9].
Generally, mutations in leptin (LEP), the leptin re-
ceptor (LEPR) and the melanocortin 4 receptor
(MC4R) represent the most common cause of mono-
genic forms of obesity and mutations within these
genes have been demonstrated to cause childhood
morbid obesity in probands of various ethnicities [10–
14]. Yet, less than 5% of cases are explained by vari-
ants in these genes in out-bred populations [15] and
possibly upto 30% in a consanguineous Pakistani
population [12, 16].
Other genes are involved in the melanocortin signal-
ling pathway and many of these have also been impli-
cated in monogenic forms of obesity, including POMC,
PCSK, SIM1, BDNF, NTRK2, SH2B1 and MRAP [6].
The most distinct monogenic syndromic forms of obes-
ity are characterized by severe early-onset obesity com-
bined with other features, including alterations in
hormone levels or dysmorphic characteristics, such as
organ developmental deformities [17, 18]. Although a few
syndromic forms of obesity, such as Alström syndrome,
are not characterized by developmental delay [19], several
are linked with varying degrees of mental retardation, in-
cluding Prader-Willi syndrome [19], SIM1 syndrome [20]
and WAGR syndrome [21]. Moreover, Bardet-Biedl syn-
drome (BBS), fragile X syndrome, Cohen syndrome and
Albright’s Hereditary Osteodystrophy are all pleotropic
disorders linked to developmental delay [19]. These rare
syndromic forms of obesity may be instigated by either
autosomal, X-linked chromosomal abnormalities or dis-
tinct genetic defects [18, 22, 23].
Worldwide, consanguineous marriage have been prac-
ticed in many populations for several generations due to
social and economic benefits [24–26] and the Pakistani
population has the highest rate of consanguinity in the
world, with frequencies of 60–76% [27, 28]. In families
with a known history of consanguineous marriages, the
degree of homozygosity in family members is 11% on
average and consanguinity thereby increases the risk of
family members suffering from autosomal deleterious re-
cessive disorders [28]. Thus genetic screening of consan-
guineous families with severe early-onset obesity,
constitutes a powerful method of identifying causal
homozygous mutations and has enabled the identifica-
tion of rare damaging variants in e.g. LEP, LEPR and
MC4R [10, 11, 29].
In the current study, we performed genetic screening
of 31 genes previously demonstrated to be involved in
childhood obesity in 23 unrelated probands from Paki-
stani families with severe early-onset obesity segregating
as an autosomal recessive trait. We have previously ex-
cluded mutations in LEP, LEPR and MC4R as causative
mutations in all probands.
Methods
Study population
Twenty-three families originating from different regions
of Pakistan were recruited for the current study. These
families were examined at Children Hospital, Pakistan
Institute of Medical Sciences (PIMS), Islamabad. Patients
were recruited between November 2015 and April 2017.
Eleven families had known consanguineous marriages.
Selection of families was based on four parameters, in-
cluding: 1) BMI of probands > 30 kg/m2 or BMI standard
deviation score (SDS) ≥3; 2) Probands displaying obesity
onset before five years of age; 3) Parents of the probands
having a BMI < 25 kg/m2, consistent with an autosomal
recessive mode of inheritance and 4) Probands not car-
rying homozygous LEP, LEPR and MC4R mutations. In
families with several affected individuals, the patient hav-
ing the most severe phenotype was selected for sequen-
cing (Table 1). Probands from all 23 families in addition
to family members from OB1 (OB1–2 and OB1–4), OB2
(OB2–1, OB2–2 and OB2–6), OB8 (OB8–1 and OB8–2)
and OB15 (OB15–1 and OB15–2) underwent targeted
resequencing (Fig. 1).
Clinical characterization
Height (cm) and waist circumference (cm) were mea-
sured with non-extendable plastic tape with the partici-
pant standing in a straight position and without shoes.
Using a digital scale, weight (kg) was measured to the
nearest 1.0 kg with the participant wearing light clothes
and no shoes. Based on interviews, information about
the age at obesity onset, other major chronic disease or
metabolic diseases (if any) segregating in the family, eat-
ing habits and physical activity were collected along with
obesity-related co-morbidities. BMI was calculated as
the weight in kilograms divided by the square of the
height in meters (kg/m2) and a BMI standard deviation
score (SDS) was calculated based on a World Health
Organization (WHO) reference population [30] using
Table 1 Clinical presentation of probands
Trait Probands
Gender (M/F) 13/10
Age at enrolment (years) 16.6 (6.81)
Age of obesity onset (years) Below the age of 5 years
Height (cm) 149.8 (24.4)
Weight (kg) 82.8 (26.0)
BMI (kg/m2) 36.5 (8.81)
BMI SDS 3.20 (1.24)
Waist circumference (cm) 102.0 (14.7)
Consanguine family (yes/no) 11/12
Family history of obesity (yes/no) 14/9
Data is presented as neither number of individuals or as mean (SD)
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the LMS method [31]. The clinical characteristics of the
study participants are presented in Table 1 and
Additional file 1.
For comparison of inbreeding coefficient, we used in-
formation from 298 Danish individuals from 61 families
which have previously been described [32].
Genomic DNA extraction
Approximately 3–5 ml venous blood samples from 31 af-
fected and 79 unaffected family members were collected
in the non-fasting state in 8.5 ml vacutainer tubes (BD
Vacutainer® ACD, Franklin Lakes NJ, USA). Following
the standard phenol-chloroform method [33] and using
QIAamp DNA Mini Kit (Qiagen, Germany), the gen-
omic DNA was extracted.
Targeted region array design
A chip-based customized nucleotide probe was used for
capturing genomic DNA of the coding regions of 31 se-
lected genes involved in monogenic forms of obesity
(ADCY3, ALMS1, ARL6, BBS1, BBS2, BBS4, BBS5, BBS7,
BBS9, BBS10, BBS12, BDNF, CCDC28B,CEP290,
Fig. 1 Pedigrees of families in which probands carry two mutations within the same gene. Possibly causal variant are denoted under the carrier ID
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CREBBP, EP300, GNAS, IER3IP1, MKKS, MKS1,
MRAP2, NTRK2, PCSK1, PHF6, POMC, SH2B1, SIM1,
TMEM67, TRIM32, TTC8 and VPS13B). Methods for
DNA extraction, target region capture and next gener-
ation sequencing have previously been described [34].
The final captured DNA libraries were sequenced ac-
cording to the manufacturer’s standard cluster gener-
ation and sequencing protocols, using the Illumina
HiSeq2000 Analyzers as paired-end 90 base pair reads.
Genotyping
Illumina Infinium Human CoreExomeBeadChip (Cor-
eExomeChip) genotyping was performed in 104 individ-
uals from 23 families of Pakistani origin and 298
individuals from 61 families of Danish origin using Illu-
mina’s HiScan system at the laboratory facilities of the
Novo Nordisk Foundation Center for Basic Metabolic
Research at Symbion, Copenhagen, Denmark. The pipe-
line and quality control protocol has previously been de-
scribed for Pakistani participants [16] and for Danish
participants [32].
Variant selection
Variants were considered possibly pathogenic if: 1) they
were variants with minor allele frequency (MAF) < 0.1%
in publically available databases [35, 36]; 2) coding non-
synonymous variants or splice variants located up to 3
nucleotides into the intron/exon boundary; 3) having
minimum depths of 20x and 4) a allelic ratio between
0.4–0.6 for heterozygous mutations.
Families were recruited based on the presence of af-
fected children from non-affected parents both from
families with known and without known consanguin-
ity. Thus, three different genetic inheritance patterns
may likely exist in the recruited families: 1) recessive,
2) compound heterozygotes and 3) heterozygous de
novo heritance. The latter mode of inheritance was
not considered despite the fact that causal heterozy-
gous mutations have been suggested for some of the
selected genes [37–40], as authentication of such po-
tentially causal heterozygous de novo mutations is
complex and sequencing information from both par-
ents is warranted.
Pathogenicity of the variants were evaluated using in
silico annotation tools [41–43] especially using Com-
bined Annotation Dependent Depletion (CADD) score
where a PHRED-scaled CADD score above 10 predicts
pathogenicity in top 10 percentile of all variants and a
score above 20 predicts the top 1 percentile [44].
Statistical analysis
Relatedness analysis was calculated as an inbreeding co-
efficient which is based on the genotyping of included
individuals. This estimates the probability of a random
locus in related individuals being identical by descent.
This was calculated using the “het” command using
PLINK [45]. Inbreeding coefficients was compared be-
tween individuals from consanguine Pakistani families,
non-consanguine Pakistani families and Danish out-
breed families using a student’s t-test in R software (ver-
sion 3.2.3; R Foundation for Statistical Computing, Bos-
ton, MA, USA).
Results
We investigated the level of relatedness in families with
and without known consanguinity using the inbreeding
coefficient. This estimates the probability of a random
locus in related individuals being identical by descent.
We found that families with known consanguinity had a
mean inbreeding coefficient of 5.6% (SD: 4.5) in contrast
to Pakistani families without consanguinity having a
mean inbreeding coefficient of 3.2% (SD: 3.0) (p = 0.003).
However, when comparing non-consanguine Pakistani
families to Danish outbred families having an inbreeding
coefficient of − 1.02% (SD: 0.65), the inbreeding coefficient
of non-consanguine Pakistani families was still significantly
higher (p = 4*10− 13). Thus, recessive inheritance-patterns
are likely to exist in Pakistani families with both known and
unknown consanguinity.
Thirty-one genes were selected based on their known
causal involvement in childhood obesity and among the
probands we identified a total of 31variants located in
ALMS1, BBS7, BBS9, BBS10, CREBPB, EP300, PCSK1,
POMC and VSP13B fulfilling the criteria for being pos-
sibly pathogenic (28 missense and three nonsense)
(Additional file 2).
Due to the large number of consanguineous families
and the high level of relatedness in families without
known consanguinity, we searched for homozygous re-
cessive variants. Yet, no homozygous pathogenic carriers
were found.
Subsequently we investigated the presence of probands
carrying two heterozygous mutations within the same
gene and found four potentially compound heterozygous
probands: 1) OB1–5 carrying the p.K1992E and the
p.I2520S in ALMS1; 2) OB2–5 carrying the p.S872 L and
p.K140R in CEP290; 3) OB8–3 carrying the p.T1512I
and p.G1890X also in CEP290; and 4) OB15–5 carrying
the p.R75X and p.R481X in BBS9 (Table 2).
OB1–5, carrying two rare missense variants in ALMS1,
displays hyperphagia in addition to severe early-onset
obesity. Sequencing of the mother (OB1–2) and the af-
fected sibling OB1–4) revealed that the variants found in
the proband (OB1–5) was not carried by the affected
sibling, nor was the mother a carrier of any of the two
ALMS1 variants found in proband (Fig. 1). In addition,
the affected individuals in OB1 did not present with the
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phenotypic characteristics of Alstrom syndrome such as
retinal degeneration, hearing loss, diabetes mellitus, di-
lated cardiomyopathy (DCM), urological dysfunction,
pulmonary, hepatic and renal failure. Thus, neither co-
segregation nor phenotypic presentation suggests that
the two variants found in OB1–5 in ALMS1 are causal
for the childhood obesity in OB1.
The probands in family OB2 and OB8 are each having
two mutations in CEP290. OB2–5 carried the p.K140R
and p.S872 L missense mutations and the proband in
OB8 (OB8–3) is carrying the p.T1512I missense muta-
tion and the p.G1890X nonsense mutation. The func-
tional prediction of the p.K140R variant based on the
CADD score, indicate only a minor impaired functional-
ity (CADD score:14.6, Table 2). This lack of presumed
functionality is supported by the lack of clinical charac-
teristic in OB2 of patients with CEP290 mutations such
as retinal degeneration, hypogonadism, polydactyly, renal
dysfunction and MR [46]. Subsequent sequencing of
CEP290 in the parents (OB2–1 and OB2–2) and sibling
(OB2–6) of OB2–5, revealed that both variants present
in the proband were inherited from the father but not
from the mother in whom none of the two variants were
present (Table 2).
The p.G1890X variant found in OB8–3 has previously
been found to cause Joubert syndrome-related disorders
(JBTS) in a homozygous manner in a Turkish family
[47]. The JBTS affects the central nervous system (brain
and spinal cord), retina and kidney and it is inherited in
autosomal recessive manner. Moreover, a high CADD
scores was found for both the missense and nonsense
variants (26.5 and 36, respectively) supporting a highly
pathogenic nature of these two mutations. Yet, sequen-
cing of CEP290 in the parents (OB8–1 and OB8–2) of
proband OB8–3 showed that the variants found in
OB8–3, both were inherited from the mother (Fig. 1).
This lack of co-segregation was also supported by the
proband (OB8–3) not displaying any of the symptoms
characteristic of the syndromes related to CEP290 muta-
tions such as JBTS, thus, we do not believe OB8–3 is
suffering from CEP290 related obesity.
The probands in OB15 is carrying the two nonsense
mutations p.R75X and p.R481X both very likely highly
deleterious mutations. Patients with BBS caused by
homozygous or compound heterozygous mutations in
BBS9 are characterized by obesity, polydactyly, renal
anomalies, retinopathy and mental retardation. OB15–5
presents with a large number of the primary BBS pheno-
types including hypogonadism, developmental delay with
learning difficulties, speech- and vision- impairment in
addition to severe childhood obesity. Moreover, sequen-
cing of BBS9 in the parents (OB15–1 and OB15–2) of
OB15–5 revealed that p.R75X was inherited from the
mother and p.R481X was inherited from the father.
Therefore, the proband OB15–5 is likely a patient with
BBS due to compound heterozygous mutations in BBS9.
Discussion
In the current study, targeted resequencing of the coding
regions of 31 selected genes known to be involved in
monogenic forms of obesity (excluding LEP, LEPR and
MC4R) was performed in 23 probands from Pakistani
families with severe early-onset obesity segregating as an
autosomal recessive trait. One compound heterozygous
proband was identified carrying two nonsense variants
in BBS9/PTHB1 (p.R75X and p.R481X) in exon 3 and
exon 14, respectively, causing BBS.
Homozygous and tri-allelic variants in BBS genes have
been reported to cause BBS phenotypes in Pakistani popu-
lation [48–50], but no prior BBS9 compound heterozy-
gous patients have been reported in non-consanguineous
Pakistani families.
Bardet-Biedl syndrome protein complex (BBSome) is a
central entity of ciliogenesis and it has 10 subunits from
Table 2 Mutation type and phenotypic presentation in probands carrying two heterozygous variants within the same gene
Family
ID
Proband
ID
Gene Identified
variants
Primary phenotype of patient Secondary
phenotypes of
patients
Phenotypic characteristic of
patients with syndromes
related to investigated gene
Mutations co-
segregation
with phenotype
OB1 OB1.5 ALMS1 p.K1992E
p.L2520S
Hyperphagia NA ALMS:
retinal degeneration, hearing
loss, diabetes mellitus,
dilated cardiomyopathy,
urological dysfunction,
pulmonary, hepatic, renal failure
No
OB2 OB2–5 CEP290 p.S872 L
p.K140R
Hyperphagia, Hypertension NA Joubert syndrome:
brain abnormalities, molar
tooth sign, hypotonia,
ataxia, hyperpneaorapnea,
ocular motor apraxia
No
OB8 OB8–3 p.T1512I
p.G1890X
Dyslipidemia NA No
OB15 OB15–5 BBS9 p.R75X
p.R481X
Hypogonadism,
Mental retardation, Obesity,
Vision impairment.
Speech impairment,
Hypertension.
Bardet-bieldel syndrome:
obesity, polydactyly, renal
anomalies, retinopathy,
mental retardation
Yes
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BBS1 to 10 [51]. BBS9, a99-kDa protein, is one of the
component of the BBSome and it has a suggested role in
associating other subunits [52]. Studies of BBS9 function
in knock down mouse and zebra fish, have revealed its
significant role in cilia biogenesis [53]. In our study, the
identified variant p.R75X is positioned in the N-terminal
domain and the p.R481X is positioned in the C-terminal
half of the PTHB1 protein. The full length BBS9 con-
tains 887 amino acids, thus, termination of the protein
after only 75 and 481 amino acids, respectively, is not
surprisingly detrimental for the function of the protein
due to non-sense mediated decay or production of trun-
cated protein [54]. Hence, we believe that these loss-of-
function mutations in BBS9 may be responsible for
structural abnormality in cilia due to reduced integrity
of BBSome proteins complex.
Previous studies examining the genetic causes of severe
early-onset obesity in Pakistani families have mainly fo-
cused on a few genes most often linked to monogenic
forms of obesity i.e. LEP, LEPR and MC4R [10, 12, 55–57],
yet, more recently, a mutation screen of multiple genes
was performed in 39 unrelated children with severe obes-
ity from consanguineous Pakistani families [56]. The study
included 21 of the 31 genes examined in the present study
and was similar to our findings with no casual mutations
in homozygous conditions identified [56]. The remaining
ten genes (CCDC28B, CREBBP, EP300, IER3IP1, MRAP2,
PHF6, SH2B1, TMEM67, VPS13B), selected in the present
study were therefore, screened for the first time in Paki-
stani families with the aim of assessing the prevalence of
damaging mutations conferring early-onset obesity. How-
ever, our findings indicate that mutations within the se-
lected 31 genes are not a common cause of severe early-
onset obesity in the Pakistani population.
No personalized treatment approach has been identi-
fied for syndromic forms of obesity and the affected in-
dividuals are generally advised to follow current general
treatment approaches, including increased physical ac-
tivity, psychomotricity (activities which integrate cogni-
tive, emotional and physical elements) and an energy
restricted diet [6].
Four potential compound heterozygous probands were
identified; however, we only claim the causal effect in
one proband. Establishing pathogenicity of missense mu-
tation is challenging and this even more so in the
present Pakistani study population, as identified variants
may be present in the unaffected background population
but may not appear in any publically available databases
which are most frequently based on Caucasian popula-
tions. However, in the present study, co-segregation ana-
lysis supported the likely causality of nonsense
mutations in which pathogenicity is highly probable.
Our investigation of the relatedness between individ-
uals in families with known consanguinity versus
families without known consanguinity, clearly indicate
that the fraction of genetic loci which show identity by
descent within a family, are of considerable proportion
even in families without known consanguinity from
population where consanguinity is frequent. This
strongly indicates that recessive disease mechanisms
generally should be considered in families of Pakistani
descent. Thus, whole exome sequencing or whole gen-
ome sequencing will likely be fruitful strategies to iden-
tify novel causal homozygous mutations in inbred
populations.
Conclusion
Among 23 Pakistani families, mutations within 31 genes
known to be involved in the development of obesity are
not a cause of severe early-onset obesity. Yet, the present
study identified one compound heterozygote patient
with BBS, thus, the presence of compound heterozygous
patients must not be overlooked in populations with a
high degree of consanguinity.
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